Features | Partner Sites | Information | LinkXpress
Sign In
Shuenn Bao Shing Corporation
Schiller
Ampronix

Boston Scientific to Acquire Electrophysiology Business

By HospiMedica International staff writers
Posted on 08 Jul 2013
Boston Scientific Corporation (Natick, MA, USA) has entered into a definitive agreement to acquire Bard EP, the electrophysiology (EP) business of C.R. Bard (Murray Hill, NJ, USA), for USD 275 million in cash.

The purchase, which is expected to significantly boost Boston Scientific’s expansion in the fast-growing market for advanced EP procedures, provides the company with a range of solutions for cardiac catheter ablations and other EP diagnosis and treatment tools. The addition of Bard EP's strong commercial team and complementary portfolio, including catheter and recording device technologies, would enable Boston Scientific to compete in the global EP market with a stronger and more comprehensive offering. The transaction is expected to close in the second half of 2013, subject to certain regulatory and customary closing conditions.

The C.R. Bard EP division, which will join the Boston Scientific rhythm management unit, is dedicated to the development and delivery of a broad range of devices for the diagnosis and treatment of cardiac arrhythmias. The company offers a full product portfolio, which includes advanced radiofrequency (RF) ablation and mapping catheters, diagnostic catheters, computer-based EP mapping and recording systems, temporary pacing electrodes, and vascular and cardiac access devices.

“We expect this acquisition to accelerate the expansion of our global electrophysiology business and we are pleased to welcome Bard EP to the Boston Scientific team,” said Mike Mahoney, president and CEO of Boston Scientific. “We believe the innovation and global reach that Bard EP delivers will meaningfully advance our position in this fast-growing market, enabling us to more effectively serve the needs of patients who suffer from cardiac arrhythmias.”

“This divestiture is consistent with our strategic plan, which is designed to position our portfolio for accelerated sales growth over time,” said Timothy Ring, chairman and CEO of C. R. Bard. “By exiting the EP business, we believe we can better direct management's attention and our capital resources toward pursuing opportunities where we believe we can achieve sustainable long-term leadership positions and provide attractive growth and returns to shareholders.”

Electrophysiology, a branch of physiology studying the relationship with electric phenomena and bodily processes such as the nervous system, is a USD 2.5 billion global market that is growing at nearly 10% annually.

Related Links:
Boston Scientific Corporation
C.R. Bard



CardioComm Solutions
Armstrong Medical Industries
Asian Healthcare Show

Channels

Critical Care

view channel

CDC Proposes the Counseling of all Males on Circumcision

The US Centers for Disease Control and Prevention (CDC; Atlanta, GA, USA) is recommending that doctors counsel parents of baby boys and teenagers, as well as men, on the benefits and risks of circumcision. The CDC's proposal opens the door to circumcision becoming a topic of conversation any time an uncircumcised male,... Read more

Women's Health

view channel

Women with PTSD Face Higher Pregnancy Risk

Suffering from post-traumatic stress disorder (PTSD) significantly increases a pregnant woman's risk of premature birth, according to a new study. Researchers at Stanford University (CA, USA) conducted a study to identify antenatal PTSD status and spontaneous preterm delivery in a retrospective cohort (2000-2012).... Read more

Hospital News

view channel
Image: Proposed site of the new University of Canberra Public Hospital (Photo courtesy of ACT).

New Hospital Planned at the University of Canberra

The government of the Australian Capital Territory (ACT, Canberra, Australia) has signed an agreement with University of Canberra (UC; Australia) to build a new hospital on its campus. The new UC Public... Read more
 
Copyright © 2000-2014 Globetech Media. All rights reserved.